{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:39:08Z","timestamp":1793457548544,"version":"4.5.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s43441-026-01013-y","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:01:39Z","timestamp":1783346499000},"page":"1569-1584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough"],"prefix":"10.1007","volume":"60","author":[{"given":"Sapna","family":"Ahuja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Kanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragati","family":"Silakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-1976","authenticated-orcid":false,"given":"Sanjeev Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8332-8057","authenticated-orcid":false,"given":"Paranjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"1013_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100713","volume":"52","author":"J Dini\u0107","year":"2020","unstructured":"Dini\u0107 J, Efferth T, Garc\u00eda-Sosa AT, et al. Repurposing old drugs to fight multidrug resistant cancers. Drug Resist Updat. 2020;52:100713.","journal-title":"Drug Resist Updat"},{"key":"1013_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.arcmed.2020.10.021","volume":"52","author":"D Ju\u00e1rez-L\u00f3pez","year":"2021","unstructured":"Ju\u00e1rez-L\u00f3pez D, Schcolnik-Cabrera A. Drug repurposing: considerations to surpass while re-directing old compounds for new treatments. Arch Med Res. 2021;52:243\u201351.","journal-title":"Arch Med Res"},{"key":"1013_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24980-2","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Aldahdooh J, Hu Y, et al. DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features. Sci Rep. 2022;12:21116.","journal-title":"Sci Rep"},{"key":"1013_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd5524","volume":"13","author":"CG Begley","year":"2021","unstructured":"Begley CG, Ashton M, Baell J, et al. Drug repurposing: misconceptions, challenges, and opportunities for academic researchers. Sci Transl Med. 2021;13:eabd5524.","journal-title":"Sci Transl Med"},{"key":"1013_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.drudis.2013.11.005","volume":"19","author":"G Jin","year":"2014","unstructured":"Jin G, Wong STC. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discov Today. 2014;19:637\u201344. https:\/\/doi.org\/10.1016\/j.drudis.2013.11.005.","journal-title":"Drug Discov Today"},{"key":"1013_CR6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nm.3595","volume":"20","author":"SM Strittmatter","year":"2014","unstructured":"Strittmatter SM. Overcoming drug development bottlenecks with repurposing: old drugs learn new tricks. Nat Med. 2014;20:590\u20131.","journal-title":"Nat Med"},{"key":"1013_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.04.004","author":"D Parisi","year":"2020","unstructured":"Parisi D, Adasme MF, Sveshnikova A, et al. Drug repositioning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs. Comput Struct Biotechnol J. 2020. https:\/\/doi.org\/10.1016\/j.csbj.2020.04.004.","journal-title":"Comput Struct Biotechnol J"},{"key":"1013_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/978-981-99-9183-9_18","volume-title":"Drugs from nature: targets, assay systems and leads","author":"P Premrajan","year":"2024","unstructured":"Premrajan P, Variyar EJ. Therapeutic targets and drug leads for reproductive health. In: Drugs from nature: targets, assay systems and leads. Springer; 2024. p. 505\u201329."},{"key":"1013_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00210-023-02651-x","volume":"397","author":"F Babaei","year":"2024","unstructured":"Babaei F, Mirzababaei M, Tavakkoli A, et al. Can nonsteroidal anti-inflammatory drugs (NSAIDs) be repurposed for fungal infection? Naunyn Schmiedebergs Arch Pharmacol. 2024;397:59\u201375.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1013_CR10","doi-asserted-by":"crossref","unstructured":"Khandelwal R, Vagha JD, Meshram RJ, et al. A comprehensive review on unveiling the journey of digoxin: past, present, and future perspectives. Cureus. 2024;16.","DOI":"10.7759\/cureus.56755"},{"key":"1013_CR11","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1001\/jamacardio.2020.3524","volume":"5","author":"J Golledge","year":"2020","unstructured":"Golledge J, Pinchbeck J, Tomee SM, et al. Efficacy of telmisartan to slow growth of small abdominal aortic aneurysms: a randomized clinical trial. JAMA Cardiol. 2020;5:1374\u201381.","journal-title":"JAMA Cardiol"},{"issue":"10","key":"1013_CR12","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3390\/biomedicines12102290","volume":"12","author":"S Sifontes-Rodr\u00edguez","year":"2024","unstructured":"Sifontes-Rodr\u00edguez S, Escalona-Monta\u00f1o AR, Mondrag\u00f3n Flores R, et al. Compared antileishmanial activity of clomiphene and tamoxifen. Biomedicines. 2024;12(10):2290. https:\/\/doi.org\/10.3390\/biomedicines12102290.","journal-title":"Biomedicines"},{"key":"1013_CR13","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","volume":"24","author":"V Parvathaneni","year":"2019","unstructured":"Parvathaneni V, Kulkarni NS, Muth A, Gupta V. Drug repurposing: a promising tool to accelerate the drug discovery process. Drug Discov Today. 2019;24:2076\u201385.","journal-title":"Drug Discov Today"},{"key":"1013_CR14","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1021\/acs.jmedchem.0c01516","volume":"64","author":"DG Brown","year":"2021","unstructured":"Brown DG, Wobst HJ. A decade of FDA-approved drugs (2010\u20132019): trends and future directions. J Med Chem. 2021;64:2312\u201338.","journal-title":"J Med Chem"},{"key":"1013_CR15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.drudis.2018.11.022","volume":"24","author":"P Polamreddy","year":"2019","unstructured":"Polamreddy P, Gattu N. The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions. Drug Discov Today. 2019;24:789\u201395.","journal-title":"Drug Discov Today"},{"key":"1013_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18:41\u201358.","journal-title":"Nat Rev Drug Discov"},{"key":"1013_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08272-z","volume":"22","author":"N Krishnamurthy","year":"2022","unstructured":"Krishnamurthy N, Grimshaw AA, Axson SA, et al. Drug repurposing: a systematic review on root causes, barriers and facilitators. BMC Health Serv Res. 2022;22:970.","journal-title":"BMC Health Serv Res"},{"key":"1013_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/bph.13798","volume":"175","author":"Y Cha","year":"2018","unstructured":"Cha Y, Erez T, Reynolds IJ, et al. Drug repurposing from the perspective of pharmaceutical companies. Br J Pharmacol. 2018;175:168\u201380.","journal-title":"Br J Pharmacol"},{"key":"1013_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/ph11020057","volume":"11","author":"JK Yella","year":"2018","unstructured":"Yella JK, Yaddanapudi S, Wang Y, Jegga AG. Changing trends in computational drug repositioning. Pharmaceuticals (Basel). 2018;11:57.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1013_CR20","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.7150\/ijbs.24612","volume":"14","author":"H Xue","year":"2018","unstructured":"Xue H, Li J, Xie H, Wang Y. Review of drug repositioning approaches and resources. Int J Biol Sci. 2018;14:1232.","journal-title":"Int J Biol Sci"},{"key":"1013_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13321-020-00450-7","volume":"12","author":"TN Jarada","year":"2020","unstructured":"Jarada TN, Rokne JG, Alhajj R. A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. J Cheminform. 2020;12:46.","journal-title":"J Cheminform"},{"issue":"1","key":"1013_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11030-025-11247-x","volume":"30","author":"S Zhang","year":"2025","unstructured":"Zhang S, Zhang R, Zheng L, et al. Drug repurposing: a promising drug discovery strategy for the treatment of emerging epidemic infectious disease. Mol Divers. 2025;30(1):241\u201371.","journal-title":"Mol Divers"},{"key":"1013_CR23","unstructured":"Pillaiyar T, Meenakshisundaram S, Manickam M. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\u2019s public news and information. 2020."},{"key":"1013_CR24","doi-asserted-by":"publisher","first-page":"18637","DOI":"10.1021\/acs.jmedchem.4c02460","volume":"67","author":"SK Guchhait","year":"2024","unstructured":"Guchhait SK. Medicinal chemistry education: molecular level understanding of all medicinal properties and innovative strategies. J Med Chem. 2024;67:18637\u20139.","journal-title":"J Med Chem"},{"key":"1013_CR25","unstructured":"Eyube M. Medicinal chemistry: scope, applications, and significance in modern science. Int J Innov Res Comput Sci Technol. 2024;9."},{"key":"1013_CR26","doi-asserted-by":"publisher","first-page":"14430","DOI":"10.1021\/acsomega.1c01314","volume":"6","author":"S Chhabra","year":"2021","unstructured":"Chhabra S, Kumar S, Parkesh R. Chemical space exploration of DprE1 inhibitors using chemoinformatics and artificial intelligence. ACS Omega. 2021;6:14430\u201341.","journal-title":"ACS Omega"},{"key":"1013_CR27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/17460441.2022.2084608","volume":"17","author":"FI Sald\u00edvar-Gonz\u00e1lez","year":"2022","unstructured":"Sald\u00edvar-Gonz\u00e1lez FI, Medina-Franco JL. Approaches for enhancing the analysis of chemical space for drug discovery. Expert Opin Drug Discov. 2022;17:789\u201398.","journal-title":"Expert Opin Drug Discov"},{"key":"1013_CR28","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1021\/acsptsci.3c00361","volume":"7","author":"AS Mishra","year":"2024","unstructured":"Mishra AS, Vasanthan M, Malliappan SP. Drug repurposing: a leading strategy for new threats and targets. ACS Pharmacol Transl Sci. 2024;7:915\u201332.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1013_CR29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/17460441.2022.2072827","volume":"17","author":"A Zi\u0119ba","year":"2022","unstructured":"Zi\u0119ba A, St\u0119pnicki P, Matosiuk D, Kaczor AA. What are the challenges with multi-targeted drug design for complex diseases? Expert Opin Drug Discov. 2022;17:673\u201383.","journal-title":"Expert Opin Drug Discov"},{"key":"1013_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13020-025-01075-4","volume":"20","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Yu L, Bi C, et al. A new paradigm for drug discovery in the treatment of complex diseases: drug discovery and optimization. Chin Med. 2025;20:40.","journal-title":"Chin Med"},{"issue":"14","key":"1013_CR31","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.3390\/ijms26146996","volume":"26","author":"M Abdelsayed","year":"2025","unstructured":"Abdelsayed M. AI-driven polypharmacology in small-molecule drug discovery. Int J Mol Sci. 2025;26(14):6996. https:\/\/doi.org\/10.3390\/ijms26146996.","journal-title":"Int J Mol Sci"},{"key":"1013_CR32","doi-asserted-by":"publisher","first-page":"13483","DOI":"10.1021\/acs.jmedchem.2c00969","volume":"65","author":"TB Callis","year":"2022","unstructured":"Callis TB, Garrett TR, Montgomery AP, et al. Recent scaffold hopping applications in central nervous system drug discovery. J Med Chem. 2022;65:13483\u2013504.","journal-title":"J Med Chem"},{"key":"1013_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/med.70026","author":"H Jiang","year":"2025","unstructured":"Jiang H, Hu Z, Yang L, et al. The evolution of benzodiazepine allosteric modulators: structural insights from historical milestones to emerging innovations in drug discovery and development. Med Res Rev. 2025. https:\/\/doi.org\/10.1002\/med.70026.","journal-title":"Med Res Rev"},{"key":"1013_CR34","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.2174\/1389557521666210210155908","volume":"21","author":"LFE Moor","year":"2021","unstructured":"Moor LFE, Vasconcelos TRA, da R. Reis R, et al. Quinoline: an attractive scaffold in drug design. Mini Rev Med Chem. 2021;21:2209\u201326.","journal-title":"Mini Rev Med Chem"},{"key":"1013_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/J.AICHEM.2024.100072","volume":"2","author":"O Kapustina","year":"2024","unstructured":"Kapustina O, Burmakina P, Gubina N, et al. User-friendly and industry-integrated AI for medicinal chemists and pharmaceuticals. Artif Intell Chem. 2024;2:100072. https:\/\/doi.org\/10.1016\/J.AICHEM.2024.100072.","journal-title":"Artif Intell Chem"},{"key":"1013_CR36","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.drudis.2022.03.006","volume":"27","author":"C Choudhury","year":"2022","unstructured":"Choudhury C, Murugan NA, Priyakumar UD. Structure-based drug repurposing: traditional and advanced AI\/ML-aided methods. Drug Discov Today. 2022;27:1847\u201361.","journal-title":"Drug Discov Today"},{"key":"1013_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2023.100039","volume":"2","author":"S Singh","year":"2024","unstructured":"Singh S, Gupta H, Sharma P, Sahi S. Advances in Artificial Intelligence (AI)-assisted approaches in drug screening. Artif Intell Chem. 2024;2:100039.","journal-title":"Artif Intell Chem"},{"key":"1013_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.therap.2020.02.006","volume":"75","author":"C Fetro","year":"2020","unstructured":"Fetro C, Scherman D. Drug repurposing in rare diseases: myths and reality. Therapie. 2020;75:157\u201360.","journal-title":"Therapie"},{"key":"1013_CR39","doi-asserted-by":"publisher","first-page":"15991","DOI":"10.1038\/s41598-024-66230-7","volume":"14","author":"SK Shah","year":"2024","unstructured":"Shah SK, Chaple DR, Masand VH, et al. Multi-target in-silico modeling strategies to discover novel angiotensin converting enzyme and neprilysin dual inhibitors. Sci Rep. 2024;14:15991.","journal-title":"Sci Rep"},{"key":"1013_CR40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/17460441.2023.2211801","volume":"18","author":"B Rocha","year":"2023","unstructured":"Rocha B, de Morais LA, Viana MC, Carneiro G. Promising strategies for improving oral bioavailability of poor water-soluble drugs. Expert Opin Drug Discov. 2023;18:615\u201327.","journal-title":"Expert Opin Drug Discov"},{"key":"1013_CR41","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2174\/1385272823666191021124443","volume":"18","author":"VS Gontijo","year":"2020","unstructured":"Gontijo VS, Viegas FPD, Ortiz CJC, et al. Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases. Curr Neuropharmacol. 2020;18:348\u2013407.","journal-title":"Curr Neuropharmacol"},{"key":"1013_CR42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/catal14110787","volume":"14","author":"Y Wei","year":"2024","unstructured":"Wei Y, Huang M, Jiang L. Advancements in serine protease inhibitors: from mechanistic insights to clinical applications. Catalysts. 2024;14:787.","journal-title":"Catalysts"},{"key":"1013_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fddsv.2024.1460100","volume":"4","author":"L Pinzi","year":"2024","unstructured":"Pinzi L, Bisi N, Rastelli G. How drug repurposing can advance drug discovery: challenges and opportunities. Front Drug Discov. 2024;4:1460100.","journal-title":"Front Drug Discov"},{"key":"1013_CR44","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/d41573-021-00190-9","volume":"21","author":"DG Brown","year":"2022","unstructured":"Brown DG, Wobst HJ, Kapoor A, et al. Clinical development times for innovative drugs. Nat Rev Drug Discov. 2022;21:793\u20134.","journal-title":"Nat Rev Drug Discov"},{"key":"1013_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/B978-0-323-99137-7.00003-4","volume-title":"Computational approaches in drug discovery, development and systems pharmacology","author":"P Mittal","year":"2023","unstructured":"Mittal P, Chopra H, Kaur KP, Gautam RK. New drug discovery pipeline. In: Computational approaches in drug discovery, development and systems pharmacology. Elsevier; 2023. p. 197\u2013222."},{"key":"1013_CR46","doi-asserted-by":"publisher","first-page":"1460100","DOI":"10.3389\/fddsv.2024.1460100","volume":"4","author":"L Pinzi","year":"2024","unstructured":"Pinzi L, Bisi N, Rastelli G. How drug repurposing can advance drug discovery: challenges and opportunities. Frontiers in Drug Discovery. 2024;4:1460100.","journal-title":"Frontiers in Drug Discovery"},{"key":"1013_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2018","unstructured":"Pushpakom S, Iorio F, Eyers PA, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2018;18:41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168.","journal-title":"Nat Rev Drug Discov"},{"key":"1013_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411325","volume":"12","author":"Z Wan","year":"2025","unstructured":"Wan Z, Sun X, Li Y, et al. Applications of artificial intelligence in drug repurposing. Adv Sci. 2025;12:2411325.","journal-title":"Adv Sci"},{"key":"1013_CR49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s42256-020-00276-w","volume":"3","author":"R Liu","year":"2021","unstructured":"Liu R, Wei L, Zhang P. A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data. Nat Mach Intell. 2021;3:68\u201375.","journal-title":"Nat Mach Intell"},{"issue":"7","key":"1013_CR50","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41573-025-01164-x","volume":"24","author":"Z Tanoli","year":"2025","unstructured":"Tanoli Z, Fern\u00e1ndez-Torras A, \u00d6zcan UO, et al. Computational drug repurposing: approaches, evaluation of in silico resources and case studies. Nat Rev Drug Discov. 2025;24(7):521\u201342.","journal-title":"Nat Rev Drug Discov"},{"key":"1013_CR51","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biodatasci-110123-025333","author":"HC Cousins","year":"2024","unstructured":"Cousins HC, Nayar G, Altman RB. Computational approaches to drug repurposing: methods, challenges, and opportunities. Annu Rev Biomed Data Sci. 2024. https:\/\/doi.org\/10.1146\/annurev-biodatasci-110123-025333.","journal-title":"Annu Rev Biomed Data Sci"},{"key":"1013_CR52","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/bmj.328.7436.410","volume":"328","author":"S Dosani","year":"2004","unstructured":"Dosani S. The nature of panic: a walk through fear in pictures and words. BMJ. 2004;328:410.","journal-title":"BMJ"},{"key":"1013_CR53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/2040620711413165","volume":"2","author":"W Rehman","year":"2011","unstructured":"Rehman W, Arfons LM, Lazarus HM. The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development. Ther Adv Hematol. 2011;2:291\u2013308.","journal-title":"Ther Adv Hematol"},{"key":"1013_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.30574\/wjbphs.2023.14.3.0257","volume":"14","author":"JA Fadnis","year":"2023","unstructured":"Fadnis JA, Sawale AV, Padmawar SS. Thalidomide: the journey from curse to boon. World J Bio Pharm Health Sci. 2023;14:149\u201359.","journal-title":"World J Bio Pharm Health Sci"},{"key":"1013_CR55","doi-asserted-by":"publisher","first-page":"108","DOI":"10.22270\/ajprd.v9i4.1018","volume":"9","author":"EA Septifani","year":"2021","unstructured":"Septifani EA, Yetti RD, Asra R. The discovery and development of sildenafil citrate. Asian J Pharm Res Dev. 2021;9:108\u201317.","journal-title":"Asian J Pharm Res Dev"},{"key":"1013_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/2141-9248.183943","volume":"6","author":"AS Elhwuegi","year":"2016","unstructured":"Elhwuegi AS. The wonders of phosphodiesterase-5 inhibitors: a majestic history. Ann Med Health Sci Res. 2016;6:139\u201345.","journal-title":"Ann Med Health Sci Res"},{"key":"1013_CR57","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2024.2336627","volume":"27","author":"BA Akorede","year":"2024","unstructured":"Akorede BA, Hassan SA, Akhigbe RE. Penile erection and cardiovascular function: effects and pathophysiology. Aging Male. 2024;27:2336627.","journal-title":"Aging Male"},{"key":"1013_CR58","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/07391102.2020.1820382","volume":"40","author":"FC Ezebuo","year":"2022","unstructured":"Ezebuo FC, Uzochukwu IC. Drug repurposing for schistosomiasis: molecular docking and dynamics investigations. J Biomol Struct Dyn. 2022;40:995\u20131009.","journal-title":"J Biomol Struct Dyn"},{"key":"1013_CR59","first-page":"80","volume-title":"Machine learning for neurodegenerative disorders","author":"B Yingngam","year":"2024","unstructured":"Yingngam B. AI-driven drug discovery and repurposing for neurodegenerative disorders. In: Machine learning for neurodegenerative disorders. CRC Press; 2024. p. 80\u2013124."},{"key":"1013_CR60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.12793\/tcp.2019.27.2.59","volume":"27","author":"K Park","year":"2019","unstructured":"Park K. A review of computational drug repurposing. Transl Clin Pharmacol. 2019;27:59\u201363. https:\/\/doi.org\/10.12793\/tcp.2019.27.2.59.","journal-title":"Transl Clin Pharmacol"},{"key":"1013_CR61","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1007\/s00210-024-03625-3","volume":"398","author":"CP Joshi","year":"2025","unstructured":"Joshi CP, Baldi A, Kumar N, Pradhan J. Harnessing network pharmacology in drug discovery: an integrated approach. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:4689\u2013703.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1013_CR62","doi-asserted-by":"crossref","unstructured":"Yingngam B. Al-driven drug discovery. Mach Learn Neurodegener Disord Adv Appl. 2025;80.","DOI":"10.1201\/9781032661025-4"},{"key":"1013_CR63","doi-asserted-by":"crossref","unstructured":"Li L, Kar S. Leveraging network pharmacology for drug discovery: integrative approaches and emerging insights. Med Drug Discov. 2025;100220.","DOI":"10.1016\/j.medidd.2025.100220"},{"key":"1013_CR64","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, et al. DrugBank 6.0: the DrugBank knowledgebase for 2024. Nucleic Acids Res. 2024;52:D1265\u201375.","journal-title":"Nucleic Acids Res"},{"key":"1013_CR65","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i7.107681","volume":"17","author":"X-N Yu","year":"2025","unstructured":"Yu X-N, Wu H-T, Wu B-X, et al. Advances and challenges in drug repurposing in precision therapeutics of colorectal cancer. World J Gastrointest Oncol. 2025;17:107681.","journal-title":"World J Gastrointest Oncol"},{"key":"1013_CR66","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.copbio.2007.09.003","volume":"18","author":"A Ciulli","year":"2007","unstructured":"Ciulli A, Abell C. Fragment-based approaches to enzyme inhibition. Curr Opin Biotechnol. 2007;18:489\u201396.","journal-title":"Curr Opin Biotechnol"},{"key":"1013_CR67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ph17010022","volume":"17","author":"SK Niazi","year":"2023","unstructured":"Niazi SK, Mariam Z. Computer-aided drug design and drug discovery: a prospective analysis. Pharmaceuticals. 2023;17:22.","journal-title":"Pharmaceuticals"},{"key":"1013_CR68","doi-asserted-by":"publisher","first-page":"1489094","DOI":"10.3389\/fmed.2024.1489094","volume":"11","author":"A Paquot","year":"2024","unstructured":"Paquot A, Deprez B, Beghyn T. Drug repurposing and phenotypic screening: innovative strategies for treating ultra-rare disorders. Front Med. 2024;11:1489094.","journal-title":"Front Med"},{"key":"1013_CR69","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13040-025-00442-z","volume":"18","author":"W Jiang","year":"2025","unstructured":"Jiang W, Ye W, Tan X, Bao Y-J. Network-based multi-omics integrative analysis methods in drug discovery: a systematic review. BioData Min. 2025;18:27.","journal-title":"BioData Min"},{"key":"1013_CR70","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2183\/pjab.96.016","volume":"96","author":"T Ito","year":"2020","unstructured":"Ito T, Handa H. Molecular mechanisms of thalidomide and its derivatives. Proc Jpn Acad Ser B Phys Biol Sci. 2020;96:189\u2013203.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"1013_CR71","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrd2030","volume":"5","author":"HA Ghofrani","year":"2006","unstructured":"Ghofrani HA, Osterloh IH, Grimminger F. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov. 2006;5:689\u2013702.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"1013_CR72","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1021\/acscentsci.0c00489","volume":"6","author":"RT Eastman","year":"2020","unstructured":"Eastman RT, Roth JS, Brimacombe KR, et al. Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19. ACS Cent Sci. 2020;6(5):672\u201383.","journal-title":"ACS Cent Sci"},{"key":"1013_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2024.02.013","volume":"64","author":"A Aboelezz","year":"2024","unstructured":"Aboelezz A, Mahmoud SH. Acyclovir dosing in herpes encephalitis: a scoping review. J Am Pharm Assoc (2003). 2024;64:102040.","journal-title":"J Am Pharm Assoc (2003)"},{"key":"1013_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010289","volume":"16","author":"AP Salam","year":"2022","unstructured":"Salam AP, Duvignaud A, Jaspard M, et al. Ribavirin for treating Lassa fever: a systematic review of pre-clinical studies and implications for human dosing. PLoS Negl Trop Dis. 2022;16:e0010289.","journal-title":"PLoS Negl Trop Dis"},{"key":"1013_CR75","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.3390\/molecules27217370","volume":"27","author":"S Peng","year":"2022","unstructured":"Peng S, Wang H, Wang Z, Wang Q. Progression of antiviral agents targeting viral polymerases. Molecules. 2022;27:7370.","journal-title":"Molecules"},{"key":"1013_CR76","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221090363","volume":"50","author":"IA Walbi","year":"2022","unstructured":"Walbi IA, Albarqi HA, Alghanim NS, et al. Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort. J Int Med Res. 2022;50:03000605221090363.","journal-title":"J Int Med Res"},{"key":"1013_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212441","volume":"25","author":"AH Al Khzem","year":"2024","unstructured":"Al Khzem AH, Gomaa MS, Alturki MS, et al. Drug repurposing for cancer treatment: a comprehensive review. Int J Mol Sci. 2024;25:12441.","journal-title":"Int J Mol Sci"},{"key":"1013_CR78","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/med.21872","volume":"42","author":"T Gamberi","year":"2022","unstructured":"Gamberi T, Chiappetta G, Fiaschi T, et al. Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness. Med Res Rev. 2022;42:1111\u201346.","journal-title":"Med Res Rev"},{"key":"1013_CR79","doi-asserted-by":"publisher","first-page":"1404092","DOI":"10.3389\/fphar.2024.1404092","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Tong X, Lu R, et al. All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia. Front Pharmacol. 2024;15:1404092.","journal-title":"Front Pharmacol"},{"key":"1013_CR80","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3389\/fphar.2017.00620","volume":"8","author":"VM Quirke","year":"2017","unstructured":"Quirke VM. Tamoxifen from failed contraceptive pill to best-selling breast cancer medicine: a case-study in pharmaceutical innovation. Front Pharmacol. 2017;8:620.","journal-title":"Front Pharmacol"},{"key":"1013_CR81","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s13023-024-03476-4","volume":"19","author":"NN Ngcobo","year":"2024","unstructured":"Ngcobo NN, Mathibe LJ. Off-label use of medicines in South Africa: a review. Orphanet J Rare Dis. 2024;19:448.","journal-title":"Orphanet J Rare Dis"},{"key":"1013_CR82","doi-asserted-by":"crossref","unstructured":"Minozzi S, Saulle R, R\u00f6sner S. Baclofen for alcohol use disorder. Cochrane Database Syst Rev. 2018.","DOI":"10.1002\/14651858.CD012557"},{"key":"1013_CR83","doi-asserted-by":"publisher","DOI":"10.5812\/ijpr-128408","volume":"21","author":"P Pooladgar","year":"2022","unstructured":"Pooladgar P, Sakhabakhsh M, Taghva A, Soleiman-Meigooni S. Donepezil beyond Alzheimer\u2019s disease? A narrative review of therapeutic potentials of donepezil in different diseases. Iran J Pharm Res. 2022;21:e128408.","journal-title":"Iran J Pharm Res"},{"key":"1013_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70071","volume":"11","author":"V Zolnowski-Kolp","year":"2025","unstructured":"Zolnowski-Kolp V, Oquendo B, Havreng-Th\u00e9ry C, et al. Effect of long-term treatment with memantine on mortality in patients with major cognitive disorders: a systematic review and meta-analysis. Alzheimer\u2019s Dement Transl Res Clin Interv. 2025;11:e70071.","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"},{"key":"1013_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1408462","volume":"15","author":"Y Shen","year":"2024","unstructured":"Shen Y, Zhao M, Zhao P, et al. Molecular mechanisms and therapeutic potential of lithium in Alzheimer\u2019s disease: repurposing an old class of drugs. Front Pharmacol. 2024;15:1408462.","journal-title":"Front Pharmacol"},{"key":"1013_CR86","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1097\/MJT.0000000000001377","volume":"28","author":"P Kory","year":"2021","unstructured":"Kory P, Meduri GU, Varon J, et al. Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. Am J Ther. 2021;28:e299\u2013318.","journal-title":"Am J Ther"},{"key":"1013_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11081063","volume":"11","author":"GG Kournoutou","year":"2022","unstructured":"Kournoutou GG, Dinos G. Azithromycin through the lens of the COVID-19 treatment. Antibiotics. 2022;11:1063.","journal-title":"Antibiotics"},{"key":"1013_CR88","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00284-024-03948-7","volume":"81","author":"A Bustos-Hamdan","year":"2024","unstructured":"Bustos-Hamdan A, Bracho-Gallardo JI, Hamdan-Partida A, Bustos-Mart\u00ednez J. Repositioning of antibiotics in the treatment of viral infections. Curr Microbiol. 2024;81:427.","journal-title":"Curr Microbiol"},{"key":"1013_CR89","doi-asserted-by":"publisher","first-page":"1148603","DOI":"10.3389\/fcimb.2023.1148603","volume":"13","author":"M Mahdizade Ari","year":"2023","unstructured":"Mahdizade Ari M, Dashtbin S, Ghasemi F, et al. Nitrofurantoin: properties and potential in treatment of urinary tract infection: a narrative review. Front Cell Infect Microbiol. 2023;13:1148603.","journal-title":"Front Cell Infect Microbiol"},{"key":"1013_CR90","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s13659-025-00521-y","volume":"15","author":"C-S Liu","year":"2025","unstructured":"Liu C-S, Yan B-C, Sun H-D, et al. Bridging chemical space and biological efficacy: advances and challenges in applying generative models in structural modification of natural products. Nat Prod Bioprospect. 2025;15:37.","journal-title":"Nat Prod Bioprospect"},{"issue":"1","key":"1013_CR91","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-pharmtox-031524-025239","volume":"65","author":"ED Kelly","year":"2025","unstructured":"Kelly ED, Ranek MJ, Zhang M, Kass DA, Muller GK. Phosphodiesterases: evolving concepts and implications for human therapeutics. Annu Rev Pharmacol Toxicol. 2025;65(1):415\u201341.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"1013_CR92","doi-asserted-by":"publisher","first-page":"2210348","DOI":"10.1080\/16583655.2023.2210348","volume":"17","author":"A Belal","year":"2023","unstructured":"Belal A, Elanany MA, Al-Karmalawy AA, Elkamhawy A, Abourehab MA, Ghamry HI, et al. Design of new captopril mimics as promising ACE inhibitors: ADME, pharmacophore, molecular docking and dynamics simulation with MM-PBSA and PCA calculations. J Taibah Univ Sci. 2023;17(1):2210348.","journal-title":"J Taibah Univ Sci"},{"key":"1013_CR93","doi-asserted-by":"publisher","first-page":"i6","DOI":"10.1093\/eurheartjsupp\/suae087","volume":"27","author":"R De Caterina","year":"2025","unstructured":"De Caterina R, Chiusolo S. Over 10 years of non-vitamin K antagonist oral anticoagulants: highlights, challenges, and future developments. Eur Heart J Suppl. 2025;27:i6\u201311.","journal-title":"Eur Heart J Suppl"},{"issue":"3","key":"1013_CR94","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1021\/acsmedchemlett.1c00624","volume":"13","author":"RL Mackman","year":"2022","unstructured":"Mackman RL. Phosphoramidate prodrugs continue to deliver, the journey of remdesivir (GS-5734) from RSV to SARS-CoV-2. ACS Med Chem Lett. 2022;13(3):338\u201347.","journal-title":"ACS Med Chem Lett"},{"key":"1013_CR95","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/molecules13051156","volume":"13","author":"MG Sandros","year":"2008","unstructured":"Sandros MG, Sarraf CB, Tabrizian M. Prodrugs in cardiovascular therapy. Molecules. 2008;13:1156\u201378.","journal-title":"Molecules"},{"key":"1013_CR96","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/molecules29030689","volume":"29","author":"Y Ding","year":"2024","unstructured":"Ding Y, Xue X. Medicinal chemistry strategies for the modification of bioactive natural products. Molecules. 2024;29:689.","journal-title":"Molecules"},{"issue":"7","key":"1013_CR97","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1039\/D5MD00095E","volume":"16","author":"S Pogash","year":"2025","unstructured":"Pogash S, Fletcher S. Razing the scaffolding: the elimination of non-catalytic functions of kinases through targeted protein degradation. RSC Med Chem. 2025;16(7):2958\u201373.","journal-title":"RSC Med Chem"},{"key":"1013_CR98","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin W-L. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024;9:92.","journal-title":"Signal Transduct Target Ther"},{"key":"1013_CR99","unstructured":"Kumari S, Verma A, Hasan S, Rai S, Yadav V, Singh AK, Singh AK, Suman A, Shadab M, Das B. Network pharmacology: a systems-based paradigm-drivenmulti-target drug discovery & development. Eur J Cardiovasc Med. 2025;15(7)."},{"key":"1013_CR100","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/molecules21040466","volume":"21","author":"F Prati","year":"2016","unstructured":"Prati F, Cavalli A, Bolognesi ML. Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer\u2019s disease. Molecules. 2016;21:466.","journal-title":"Molecules"},{"key":"1013_CR101","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/picr.picr_70_24","volume":"16","author":"K Saranraj","year":"2025","unstructured":"Saranraj K, Kiran PU. Drug repurposing: clinical practices and regulatory pathways. Perspect Clin Res. 2025;16:61\u20138.","journal-title":"Perspect Clin Res"},{"key":"1013_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fddsv.2024.1460100","volume":"4","author":"L Pinzi","year":"2024","unstructured":"Pinzi L, Bisi N, Rastelli G. How drug repurposing can advance drug discovery: challenges and opportunities. Front Drug Discov. 2024;4:1\u20139. https:\/\/doi.org\/10.3389\/fddsv.2024.1460100.","journal-title":"Front Drug Discov"},{"key":"1013_CR103","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3389\/fphar.2020.00420","volume":"11","author":"RJ Tyson","year":"2020","unstructured":"Tyson RJ, Park CC, Powell JR, et al. Precision dosing priority criteria: drug, disease, and patient population variables. Front Pharmacol. 2020;11:420.","journal-title":"Front Pharmacol"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01013-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01013-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01013-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:02:52Z","timestamp":1793412172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01013-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1013"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-01013-y","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}